Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting

Patients with severe OCS-dependent asthma can be considered a subgroup of asthma patients with severe disease and great risk of complications, related to chronic OCS use. The introduction of biological drugs has represented a turning point in the therapeutic strategy for severe asthma, offering a va...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitale, Carolina, Maglio, Angelantonio, Pelaia, Corrado, D’Amato, Maria, Ciampo, Luigi, Pelaia, Giulia, Molino, Antonio, Vatrella, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918073/
https://www.ncbi.nlm.nih.gov/pubmed/36769635
http://dx.doi.org/10.3390/jcm12030985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918073/
https://www.ncbi.nlm.nih.gov/pubmed/36769635
http://dx.doi.org/10.3390/jcm12030985

Ejemplares similares